Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Viridian Therapeutics Inc (NQ: VRDN )

20.14 -1.50 (-6.93%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viridian Therapeutics Inc

< Previous 1 2 3 4 5 6 Next >
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Viridian Therapeutics (VRDN) Stock Jumps 60% on Promising Clinical Trial
Viridian Therapeutics is among the biggest winners on Monday as it released encouraging clinical data, thus skyrocketing VRDN stock. 
Via InvestorPlace
Gold Drops Over 1%; Viridian Therapeutics Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones around 170 points on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
  
Via Benzinga
Snap, Gilead Sciences And Some Other Big Stocks Moving Higher On Monday
Magic Empire Global Limited (NASDAQ: MEGL) shares climbed 80.9% to $14.87 on volatility following the company's IPO earlier this month. 
Via Benzinga
Viridian's Thyroid Eye Disease Candidate Shows Encouraging Early Data, Shares Surge
Via Benzinga
Recap: Viridian Therapeutics Q2 Earnings
  Viridian Therapeutics (NASDAQ:VRDN) reported its Q2 earnings results on Monday, August 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Dow Surges Over 100 Points; Crude Oil Falls Sharply
U.S. stocks traded turned higher midway through trading, with the Dow Jones gaining more than 100 points on Monday. 
Via Benzinga
Why Viridian Therapeutics Is Trading Higher By Around 58%, Here Are 67 Stocks Moving In Monday's Mid-Day Session
Gainers Sunrise New Energy Co. Ltd. (NASDAQ: EPOW) shares jumped 118.2% to $4.4948. Sunrise New Energy said that the company changed its name from Global Internet of the People, Inc. to Sunrise New... 
Via Benzinga
Viridian Therapeutics: Q1 Earnings Insights
Viridian Therapeutics (NASDAQ:VRDN) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
Via Benzinga
Viridian Therapeutics To Test Next-Gen IGF-1R Antibody In Thyroid Eye Disease
The  
Via Benzinga
New Contender Viridian Takes Aim At Horizon's Eye Drug, And Rockets
Horizon has the only approved thyroid eye disease treatment in the U.S., for now. 
Via Investor's Business Daily
Viridian Therapeutics (NASDAQ: VRDN) Shares Positive Clinical Data from Phase 1/2 Trial of VRDN-001 for Treatment of Thyroid Eye Disease
Viridian Therapeutics, Inc. (NASDAQ: VRDN) is engaged as a biotechnology company, which is focused on the research and development of 
Via Spotlight Growth
U.S. Stocks Edge Lower; NY Empire State Manufacturing Index Drops In August
U.S. stocks traded slightly lower this morning, with the Dow Jones dropping around 40 points on Monday. 
Via Benzinga
Why Viridian Therapeutics Stock Is Soaring Today
Viridian Therapeutics Inc (NASDAQ: VRDN) shares are trading higher Monday after the company reported better-than-expected top-line results and announced initial clinical data from its ongoing trial of... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
Earnings Scheduled For August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022
Upgrades 
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Viridian Therapeutics, Inc. with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
110 Biggest Movers From Friday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital. 
Via Benzinga
56 Stocks Moving In Friday's Mid-Day Session
Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to... 
Via Benzinga
Viridian Therapeutics: Q4 Earnings Insights
Viridian Therapeutics (NASDAQ:VRDN) reported its Q4 earnings results on Thursday, March 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
Earnings Preview: Viridian Therapeutics
Viridian Therapeutics (NASDAQ:VRDN) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement.... 
Via Benzinga
Earnings Scheduled For May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter. 
Via Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock moved upwards by 27.0% to $2.54 during Friday's regular session. The current volume of 40.0 million shares is 1123.6% of... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2021
Upgrades Macquarie upgraded the previous rating for ZTO Express (Cayman) Inc (NYSE: 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.